Purging effect of dibutyl phthalate on leukemia cells involves fas independent activation of caspase-3/CPP32 protease

Cancer Letters

Volumn 186, Issue 2, 2002, Pages 177-182

  Wang, Li Sheng ^a   Liu, Hong Jun ^a   Zhang, Jin Hui ^a   Wu, Chu Tse ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Apoptosis; Caspase 3 CPP32; Dibutyl phthalate; Leukemia cells

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; FAS ANTIGEN; N ACETYLASPARTYLGLUTAMYLVALYLASPARTIC ACID ALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHTHALIC ACID DIBUTYL ESTER; PROTEINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA; MOLECULAR BIOLOGY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACIDS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE; CELL SURVIVAL; DIBUTYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; IN SITU NICK-END LABELING; LEUKEMIA; TUMOR CELLS, CULTURED; U937 CELLS; UP-REGULATION;

EID: 0037027751     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00324-5     Document Type: Article

References (14)

1. Wu C.T., Pei X.T., Cao J.R., Xue H.H. A new pharmacological activity of dibutyl phthalate (DBP) on selective elimination of tumor cells from bone marrow. Leuk. Res. 17:1993;557-560.
2. Wang L., Wu C., Pei X., Xu L., Cao J., Xue H., Yang K., Teng A., Ji S. Dibutyl phthalate purged autologous bone marrow transplant in the treatment of leukemia. Leuk. Res. 20:1996;343-348.
3. Wang L., Wu C., Pei X., Xu L., Cao J., He F. Purging effect of dibutyl phthalate on leukemic cells associated with apoptosis. Leuk. Res. 20:1996;989-992.
4. Saini K.S., Walker N.I. Biochemical and molecular mechanisms regulating apoptosis. Mol. Cell. Biochem. 178:1998;9-25.
5. Nunez G., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 17:1998;3237-3245.
6. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
7. Datta R., Banach D., Kojima H., Talanian R.V., Alnemri E.S., Wong W.W., Kufe D.W. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood. 88:1996;1936-1943.
8. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell. 91:1997;443-446.
9. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
10. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
11. Gervais F.G., Thornberry N.A., Ruffolo S.C., Nicholson D.W., Roy S. Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide. J. Biol. Chem. 273:1998;17102-17108.
12. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:1997;294-298.
13. Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (Apo-fas) receptor/ligand system in drug induced apoptosis in leukemia cells. Nat. Med. 2:1996;547-557.
14. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.